Cost
What a GLP-1 costs you when your plan says no
The cheapest GLP-1 is almost always a covered one. Work the routes below in order, and only pay the full price once the ones in front of it are closed to you.
Cost questions, answered from the documents
What each drug costs, and where
- Wegovy cost with insurance and self-payWegovy’s cost depends on coverage, formulation and offer eligibility. Current manufacturer pen offers differ from commercial copay savings, and an introductory fill is not the ongoing price. Confirm the exact route before comparing totals.
- Zepbound savings card: who it pays, how much, and why it gets rejectedOnly with commercial insurance. If your plan covers the Zepbound pen, you can pay as little as $25 a fill. If it doesn't, the card sets a cash price instead. Medicare, Medicaid, TRICARE and VA members can't use it.
- Where is brand Zepbound cheapest without insurance?LillyDirect, TrumpRx and a retail pharmacy using Lilly's self-pay card all charge $299 to $449 a month, by dose. Costco's own member price is higher. Refill within 45 days, or the top doses cost $699.
- What does Foundayo (orforglipron) cost, and will insurance or Medicare pay?Paying cash, Foundayo costs $149 to $299 a month depending on the dose. With commercial coverage the savings card can bring it to $25. On Medicare Part D, the GLP-1 Bridge covers it for $50 if you qualify.
- What does the Wegovy pill cost, with and without insurance?Paying cash, the Wegovy pill costs $149 a month at the 1.5 mg starting dose, $199 at 4 mg and $299 at 9 and 25 mg. Commercial coverage can bring it to $25; Medicare's Bridge charges $50.
- Costco GLP-1 prices: what Wegovy, Ozempic and Zepbound cost at the pharmacyWith a Costco membership and no insurance, Wegovy and Ozempic cost the same as buying from Novo: $149 to $299 for the pill, $199 then $349 for the pen. Zepbound costs more at Costco than at LillyDirect.
What a telehealth program adds to the drug price
- Ro Wegovy and Zepbound cost: the membership, the drug, and how it compares with LillyDirect and TrumpRxRo charges two things: a membership ($39 the first month, then $74 to $149 a month by plan) and the drug. Its cash drug prices match NovoCare, LillyDirect and TrumpRx, so the membership is what you pay extra.
- Hims GLP-1 cost with and without insurance: the membership, the drug, and what coverage changesHims is cash pay: $39 the first month, then $149 a month for the membership, plus the drug from $149 (Wegovy pill) or $299 (Zepbound). Hims doesn't bill insurance, so coverage helps only if you fill through your plan instead.
- WeightWatchers Wegovy cost: the Med+ membership, the drug, and what insurance coversWeightWatchers Med+ costs $25 the first month, then $74 a month on a 12-month plan or $84 on six. Wegovy is billed separately at Novo's price: $199 for two starter pen fills, then $349; the pill is $149 to $299.
Will a plan pay for it?
- Medicare payment plan: spreading covered GLP-1 costsThe Medicare Prescription Payment Plan spreads covered Part D costs across the calendar year. It changes when you pay, not which prescriptions qualify or their total cost. Your plan must first cover the medication.
- Do GLP-1 copay cards count toward your deductible?Not necessarily. A manufacturer card can lower what you pay at the pharmacy while the plan credits a different amount toward its deductible. Ask how assistance is recorded under your exact benefit before budgeting around it.
- Insurance stopped covering Wegovy or ZepboundFind out what changed: eligibility, the drug list, authorization or the pharmacy claim. Keep the written notice and effective date, then use your plan’s exception or appeal process for the specific problem.
- GLP-1 costs: deductible vs. out-of-pocket maximumA covered prescription can still be expensive before your deductible. The out-of-pocket maximum applies to covered in-network care; it does not automatically include excluded medication or every cash purchase.
- Can insurance reimburse a GLP-1 you paid for in cash?Sometimes, but a receipt alone does not establish coverage. Ask your plan about a payment request for the exact prescription and fill date. Medicare Part D requires a written request for medication already purchased.
- Medicare tiering exceptions for GLP-1 drugsA tiering exception asks a Medicare drug plan to lower cost sharing. It is different from getting a nonformulary drug covered, and requires medical support from your prescriber.
- Which insurance plans cover Zepbound and Wegovy?No insurer covers Zepbound or Wegovy for everyone. Your employer or plan decides whether to buy weight-loss drug coverage; the insurer only sets the criteria when it does. Check your own plan's formulary, not the insurer's name.
- Does your PBM cover Zepbound? CVS Caremark, Express Scripts and Optum RxMaybe. Starting October 1, 2026, CVS Caremark adds Zepbound back as a preferred drug on its template formularies, but your employer can still customize coverage. Express Scripts and Optum Rx already list the Zepbound pen.
- Your plan excludes weight-loss drugs. Does that rule out Wegovy and Zepbound for every use?Not always. The federal rule and most plan exclusions target the use, not the drug. Wegovy can still be covered for heart risk or MASH, and Zepbound for sleep apnea, under each plan's own criteria. Some plans exclude those too.
- Will insurance cover Zepbound for sleep apnea? Medicare, Medicaid and job-based plansOften, even where weight loss is excluded. Medicare Part D can cover Zepbound for sleep apnea through your plan, not the $50 Bridge. Commercial plans that cover it want a sleep study and a BMI of at least 30.
- Does TRICARE cover Wegovy or Zepbound in 2026?On TRICARE Prime or Select, yes, with prior authorization and a network prescriber; the formulary lists Wegovy and Zepbound at $48 retail. TRICARE For Life and direct-care-only beneficiaries lost weight-loss coverage on August 31, 2025.
- Does Medicare cover Wegovy to lower heart attack and stroke risk?Yes, through your Part D plan. Plans can cover Wegovy to lower heart attack and stroke risk, often with prior authorization and your plan's own cost-sharing. The $50 GLP-1 Bridge covers weight management, not this use.
Getting your plan to approve it
- How long does GLP-1 prior authorization take?The clock depends on your coverage and request. For Part D benefits, CMS describes 72-hour standard and 24-hour expedited decisions; an exception clock starts when the prescriber’s supporting statement arrives.
- GLP-1 authorization renewal and maintenance coverageRenewal can require proof of response and continued treatment, even after an initial approval. Keep the original baseline, current clinical record and approval end date. Use the continuation criteria for your exact plan and indication.
- Pharmacy rejection or GLP-1 coverage denial?A rejected pharmacy transaction may need correction or a coverage request. Ask for the reason and the plan’s formal decision. A pharmacy message alone may not provide the notice or appeal instructions you need.
- Check GLP-1 coverage before open enrollmentCompare the exact plan, drug, diagnosis and pharmacy before enrolling. A familiar insurer name does not establish coverage, and a low premium can hide expensive prescription costs.
- GLP-1 step therapy: evidence for an exceptionA step-therapy exception asks the plan to waive a required treatment trial. Your prescriber must explain why the required alternative is unsuitable; the request still depends on the plan’s coverage rules.
- What do Zepbound prior authorization criteria require at each insurer and PBM?Most criteria want a BMI of 30, or 27 with a weight-related condition. You'll also need a diet and exercise record. Aetna's BMI 35 policy sets a higher bar. Renewal usually needs 5% weight loss.
- What do insurers require for Wegovy prior authorization?Most criteria want a BMI of 30, or 27 with a weight-related condition. You'll also need a diet and exercise record. Renewal usually needs 5% weight loss. Heart-risk use asks for a BMI of 27 and past heart disease.
- What should you say when you call your insurer about GLP-1 coverage?Ask who runs your drug benefit, whether the drug is covered and for which uses, and for the prior authorization criteria. If you're denied, ask for the reason and criteria in writing. Log every call.
- Can you appeal your employer plan's weight-loss drug exclusion?Yes, you can appeal, and the plan must review it and give you your file free. An exclusion is hard to overturn, though. External review covers denials involving medical judgment, and the reviewer decides whether yours does.
1. Appeal before you pay anything
An appeal costs you nothing, and an independent reviewer can overrule your plan. The deadlines are short, so count yours now with the appeal deadline calculator, then follow the denial routes in order.
2. On Medicare? Check the $50 Bridge
Medicare law still excludes drugs used for weight loss. A separate demonstration pays for some GLP-1s at a fixed copay, and it has rules of its own. What the Bridge requires.
CMS is running a short-term demonstration, the Medicare GLP-1 Bridge, giving eligible Part D beneficiaries access to certain GLP-1 drugs between July 1, 2026 and December 31, 2027, at a $50 monthly copay.
Centers for Medicare & Medicaid Services, effective August 2026 · source
The Bridge runs outside the normal Part D benefit. The $50 does not count toward your true out-of-pocket total, and low-income subsidies do not apply to it.
Centers for Medicare & Medicaid Services, effective August 2026 · source
Coupons and discount programs may not be applied to Medicare GLP-1 Bridge claims, so the $50 Bridge copay does not stack with manufacturer help.
Centers for Medicare & Medicaid Services, effective August 2026 · source
3. Savings cards and self-pay programs are different things
A copay card lowers what you pay on a covered commercial prescription. A self-pay program sets a cash price when nothing covers it. Who each one excludes is where most people get caught out.
Read August 2026
Manufacturer copay savings cards exclude anyone enrolled in a government program. Lilly's Zepbound card requires that you are "not enrolled in any state, federal, or government funded healthcare program," naming Medicaid, Medicare, Medigap, DoD, VA and TRICARE.
Eli Lilly and Company · source
A self-pay program is a different thing. Novo Nordisk states that patients enrolled in government, state or federally funded programs are able to pay the self-pay price for their prescription.
Novo Nordisk · source
If you hold both commercial and government coverage, Novo counts you as government-insured for the savings offer. Federal Employees Health Benefits, Affordable Care Act exchange plans and state employee plans are explicitly not government programs for this purpose.
Novo Nordisk · source
Read September 2026
Lilly's separate self-pay KwikPen card "is for self‑paying (cash) patients only": you agree not to seek reimbursement "from any third‑party payer, including private insurance or state or federal healthcare programs, nor apply those costs toward any deductible or true out‑of‑pocket requirements." Its eligibility list is residency in the United States or Puerto Rico and age 18 or older, with no government-program exclusion, and Lilly's savings page offers it under the Medicare, "Government (other)" and "No insurance" choices.
Eli Lilly and Company, Zepbound self-pay KwikPen terms and conditions, effective August 2026 · source · savings page
4. Did your pharmacy benefit drop a drug?
Your plan's pharmacy benefit manager decides which brand it pays for, and that list moves. Does your PBM cover Zepbound? CVS Caremark, Express Scripts and Optum Rx
Where to go next
- If you are deniedThe appeal routes first, then the cash-pay fork if the appeal fails or you cannot wait.
- Your plan typeMedicare, Medicaid and employer plans each price this differently.
- Your stateWhat Medicaid covers where you live, with the documents behind it.
Where this comes from
Read August 2026 unless marked.
- Centers for Medicare & Medicaid Services, effective August 2026 — www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-
- Eli Lilly and Company — Open the document
- Novo Nordisk — Open the document
- Eli Lilly and Company, Zepbound self-pay KwikPen terms and conditions, effective August 2026 — Open the document (read September 2026)